Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis

Journal of Hepatology

Volumn 27, Issue 4, 1997, Pages 645-653

  Saló, Joan ^a   Ginès, Angels ^a   Ginès, Pere ^a   Piera, Carlos ^a   Jiménez, Wladimiro ^a   Guevara, Mónica ^a   Fernández Esparrach, Glòria ^a   Sort, Paul ^a   Bataller, Ramón ^a   Arroyo, Vicente ^a   Rodés, Joan ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Ascites; Cirrhosis; Norepinephrine; Paracentesis; Plasma volume; Renin; Transvascular escape rate of albumin

Indexed keywords

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; CLINICAL ARTICLE; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; NORADRENALIN BLOOD LEVEL; PARACENTESIS; PLASMA RENIN ACTIVITY; PLASMA VOLUME; PRIORITY JOURNAL; TREATMENT OUTCOME; VASOCONSTRICTION;

EID: 0030819439     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80081-5     Document Type: Article

References (63)

1. Ascione A, Burroughs AK. Paracentesis for ascites in cirrhotic patients. Gastroenterol Int. 3:1990;120-123.
2. Arroyo V, Ginés A, Saló J. A European survey on the treatment of ascites in cirrhosis. J Hepatol. 21:1994;667-672.
3. Ginès P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 93:1987;234-241.
4. Salerno F, Badalamenti S, Incerti P, Jempini S, Restelli B, Bruno S, et al. Repeated paracentesis and i.v. albumin infusion to treat tense ascites in cirrhotic patients. A safe alternative therapy. J Hepatol. 5:1987;102-108.
5. Titó L, Ginès P, Arroyo V, Planas R, Panés J, Rimola A, et al. Total paracentesis associated with intravenous albumin in the management of patients with cirrhosis and ascites. Gastroenterology. 98:1990;146-151.
6. Planas R, Ginès P, Arroyo V, Llach J, Panés J, Vargas V, et al. Dextran 70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology. 99:1990;1736-1744.
7. Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 325:1991;829-835.
8. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology. 13:1991;707-713.
9. Hagège H, Ink O, Ducreux M, Pelletier G, Buffet C, Étienne JP. Traitement de l'ascite chez les malades atteints de cirrhose sans hyponatrémie ni insuffisance rénale. Résultats d'une étude randomisée comparant les diurétiques et les fonctions compensées par l'albumine. Gastroenterol Clin Biol. 16:1992;751-755.
10. Fassio E, Terg R, Landeira G, Abecasis R, Salemne M, Podesta A, et al. Paracentesis with dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study. J Hepatol. 14:1992;310-316.
11. Solà R, Vila MC, Andreu M, Oliver MI, Coll S, Gana J, et al. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study. J Hepatol. 20:1994;282-288.
12. Ginès A., Planas R, Angeli P, Guarner C, Salerno F, Ginès P, et al. Treatment of patients with cirrhosis and refractory ascites by LeVeen shunt with titanium tip. Comparison with therapeutic paracentesis. Hepatology. 22:1995;124-131.
13. Knauer CM, Lowe HM. Hemodynamics in the cirrhotic patient during paracentesis. N Engl J Med. 276:1967;491-496.
14. Guazzi M, Polese A, Magrini F, Fiorentini C, Olivari MT. Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med. 59:1975;165-170.
15. Simon DM, McCain JR, Bonkovsky HL, Wells JO, Hartle DK, Galambos JT. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology. 7:1987;423-429.
16. Panos MZ, Moore K, Vlavianos P, Chambers JB, Anderson JV, Gimson AES, et al. Single, total paracentesis for tense ascites: sequential hemodynamic changes and right atrial size. Hepatology. 11:1990;662-667.
17. Pozzi M, Osculati G, Boari G, Serboli P, Colombo P, Lambrughi C, et al. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites. Gastroenterology. 106:1994;709-719.
18. Nelson WP, Rosenbaum JD, Strauss MB. Hyponatremia in hepatic cirrhosis following paracentesis. J Clin Invest. 30:1951;738-744.
19. Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure. Lancet. ii:1956;1121-1125.
20. Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology. 94:1988;1493-1502.
21. Wang SS, Lu CW, Chao Y, Lee FY, Chen TW, Lin HC, et al. Total paracentesis in non- alcoholic cirrhotics with massive ascites: mid-term effects on systemic and hepatic haemodynamics and renal function. J Gastroenterol Hepatol. 9:1994;592-596.
22. Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, et al. Randomized trial comparing albumin, dextran-70 and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 111:1996;1002-1010.
23. Terg R, Berreta J, Abecasis R, Romero G, Boerr L. Dextran administration avoids hemodynamic changes following paracentesis in cirrhotic patients. A safe and inexpensive option. Dig Dis Sci. 37:1992;79-83.
24. García-Compeéan D, Villarreal JZ, Cuevas HB, Cantú DAG, Estrella M, Támez EG, et al. Total therapeutic paracentesis (TTP) with and without intravenous albumin in the treatment of cirrhotic tense ascites: a randomized controlled trial. Liver. 13:1993;233-238.
25. Luca A, García-Pagán JC, Bosch J, Feu F, Jiménez W, Ginès A, et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. Hepatology. 22:1995;753-758.
26. Gabuzda G, Traeger H, Davidson C. Hepatic cirrhosis effects of sodium chloride administration and restriction and of abdominal paracentesis on electrolyte and water balance. J Clin Invest. 33:1954;780-789.
27. Hepatology Strauss RM, Boyer TD. Diagnosis and management of cirrhotic ascites. Zakim D, Boyer TD. 3rd ed. A Textbook of Liver Disease. 1:1996;764-790 W.B. Saunders, Philadelphia.
28. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition of diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 23:1996;164-176.
29. Henriksen J, Winkler K. Transvascular escape rate of albumin in liver cirrhosis, and its possible role in formation of ascites. Scand J Gastroenterol. 12:1977;877-884.
30. Polligore M, Tono M. Blood volume. Gottschalk A, Hoffer PB, Potchen EJ, Berger HJ. 2nd ed. Diagnostic Nuclear Medicine. 1988;690-698 Williams and Wilkins, Baltimore.
31. Saha GP. In vitro and in vivo nonimaging tests. Saha GB. 3rd ed. Fundamentals of Nuclear Pharmacy. 1992;223-224 Springer-Verlag, New York.
32. LaVilla G, Salmerón JM, Arroyo V, Bosch J, Ginès P, Garcia-Pagán JC, et al. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension. Gastroenterology. 102:1992;2114-2119.
33. Garcia-Pagán JC, Salmerón JM, Feu F, Luca A, Ginès P, Pizcueta P, et al. Effects of low-sodium diet and spironolactone in patients with compensated cirrhosis. Hepatology. 19:1994;1095-1099.
34. Asbert M, Jiménez W, Gaya J, Ginès P, Arroyo V, Rivera F, et al. Assessment of the renin- angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. J Hepatol. 15:1992;179-183.
35. Peuler JD, Johnson GA. Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine. Life Sci. 21:1977;625-636.
36. Abboud F, Thames M. Interaction of cardiovascular reflexes in circulatory control. Shepherd JT, Abboud FM, Geiger SR. Handbook of Physiology. The Cardiovascular System. 3:1983;675-753 Waverly Press, Baltimore. Section 2.
37. Goetz KL, Bond BD, Smith WE. Effect of moderate hemorrhage in humans on plasma ADH and renin. Proc Soc Exp Biol Med. 145:1974;277-280.
38. Hesse B, Nielsen I, Hansen JF. The effect of reduction in blood volume on plasma renin activity in man. Clin Sci Mol Med. 49:1975;515-517.
39. Hesse B, Nielsen I, Ring-Larsen H, Hansen JF. The influence of acute blood volume changes on plasma renin activity in man. Scand J Clin Lab Invest. 38:1978;155-161.
40. Parving H-H, Ranek L, Lassen NA. Increased transcapillary escape rate of albumin in patients with cirrhosis of the liver. Scand J Clin Lab Invest. 37:1977;643-648.
41. Fleck A, Hawker F, Wallace PI, Raines G, Trotters J, Ledingham IM, et al. Increased vascular permeability; a major cause of hypoalbuminaemia in disease and injury. Lancet. i:1985;781-783.
42. Parving H-H, Rasmussen SM. Transcapillary escape rate of albumin and plasma volume in short and long-term juvenile diabetes. Scand J Clin Lab Invest. 32:1973;81-87.
43. Hesse B, Parving H-H, Lund-Jacobsend H, Noer I. Transvascular escape rate of albumin is increased in subjects with congestive heart failure. Circ Res. 39:1976;358-2.
44. Demling R, Burns. Staub NC, Taylor AE. Edema. 1984;579-599 Raven Press, New York.
45. Falk JL, Rackow EC, Weil MH. Colloid and crystalloid fluid resuscitation. Shoemaker WC, Ayres S, Gvenkik A, Holbrook PR, Thompson WL. 2nd ed. Textbook of Critical Care. 1989;1055-1073 W.B. Saunders, Philadelphia.
46. Klotz U, Kroemer H. Clinical pharmacokinetic considerations in the use of plasma expanders. Clin Pharmacokinet. 12:1987;123-135.
47. Arroyo V, Ginès P, Jiménez W, Rodés J. Ascites, renal failure, and electrolyte disorders in cirrhosis. Pathogenesis, diagnosis and treatment. McIntyre N, Benhamou J, Bircher J, Rizzetto M. Oxford Textbook of Hepatology. 1:1991;429-470 Oxford University Press, Oxford.
48. Schrier R, Arroyo V, Bernardi M, Epstein M, Henriksen J, Rodés J. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water reterntion in cirrhosis. Hepatology. 8:1988;1151-1157.
49. Schrier RW, Niederbeger M, Weigert A, Ginés P. Peripheral arterial vasodilation: determinant of functional spectrum of cirrhosis. Semin Liver Dis. 14:1994;14-22.
50. Saló J, Ginés A, Anibarro L, Jiménez W, Clàra J, Ginès P, et al. Effect of upright tilting and physical exercise on endogenous nueurohumoral systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone and norepinephrine levels. Hepatology. 22:1995;479-487.
51. Henriksen JH, Bendtsen F, Sorensen TI, Stadeager C, Ring Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology. 97:1989;1506-1513.
52. Henriksen JH, Bendtsen F, Gerbes AL, Christensen NJ, Ring Larsen H, Sorensen TI. Estimated central blood volume in cirrhosis: relationship to sympathetic nervous activity, beta adrenergic blockade and atrial natriuretic factor. Hepatology. 16:1992;1163-1170.
53. Henriksen J, Moller S. Hemodynamics, distribution of blood volume, and kinetics of vasoactive substances in cirrhosis. Epstein M. 4th ed. The Kidney in Liver Disease. 1996;241-258 Hanley & Belfus, Philadelphia.
54. Moller S, Sondergaard L, Mogelvang J, Henriksen O, Henriksen JH. Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology. 22:1995;472-478.
55. Wong F, Liu P, Allidina Y, Blendis L. Central blood volume in cirrhosis: measurement with radionuclide angiography. Hepatology. 19:1994;312-321.
56. Wong PY, Carroll RE, Lipinski TL, Capone RR. Studies on the renin-angiotensin-aldosterone system in patients with cirrhosis and ascites: effect of saline and albumin infusion. Gastroenterology. 77:1979;1171-1176.
57. Shapiro MD, Nichols KM, Groves BM, Kludge R, Chung H-M, Bichet DG, et al. Interrelationship between cardiac output and vascular resistance as determinants of "effective arterial blood volume" in patients with cirrhosis. Kidney Int. 28:1985;206-211.
58. Nicholls KM, Shapiro MD, Van Putten VJ, Kludge R, Chung H-M, Bichet DG, et al. Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Circ Res. 56:1985;457-461.
59. Blendis LM, Sole MJ, Campbell P, Lossing AG, Greig PD, Taylor BR, et al. The effect of peritoneovenous shunting on catecholamine metabolism in patients with hepatic ascites. Hepatology. 7:1987;143-148.
60. Epstein M. Renal effects of head-out water immersion in humans: a 15-year update. Physiol Rev. 72:1992;563-621.
61. Laragh JH, Sealey JE. Renin-angiotensin-aldosterone system and the renal regulation of sodium, potassium and blood pressure homeostasis. Windhager EE. Handbook of Physiology. Renal Physiology. 1992;1409-1541 Oxford University Press, New York.
62. Vila MC, Solà R, Molina L, Andreu M, Coll S, Gana J, et al. Hemodynamic changes in patients with effectie hypovolemia after total paracentesis of ascites (Abstract). Hepatology. 22:1995;163A.
63. Ruíz del Arbol L, Monescillo A, Jiménez W, Garcia-Plaza A, Arroyo V, Rodés J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology (in press).